The expression of Nuclear Factor-κB in a rat model of polycystic ovary syndrome

被引:0
|
作者
Wang, Hui-lan [1 ]
Xu, Xia [1 ]
Zheng, Zhi-qun [1 ]
机构
[1] Fujian Med Univ, Affiliated Union Hosp, Dept Gynecol & Obstet, Fuzhou, Fujian, Peoples R China
来源
关键词
Polycystic ovary syndrome; NF-kappa B; INSULIN-RESISTANCE; WOMEN; RISK; PCOS;
D O I
10.12891/ceog3873.2018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To discuss the effect of Nuclear Factor-kappa B (NF-kappa B) in poly cystic ovary syndrome (PCOS). Materials and Methods: Thirty female SD rats were divided into a control group (n=15) and a PCOS group (n=15). The expression of NF-kappa B in ovaries of each group was monitored by way of immunohistochemistry and quantitative PCR. Results: The expression of NF-kappa B p65 in ovaries by immunohistochemical and fluorescence quantitative PCR shows no significant difference between the two groups (p> 0.01). Conclusion: The pathogenesis of this research model has no obvious association with NF-kappa B.
引用
收藏
页码:276 / 279
页数:4
相关论文
共 50 条
  • [41] Hyperglycemia stimulates activation of nuclear factor κB (NFκB) in mononuclear cells (MNC) of women with polycystic ovary syndrome (PCOS).
    Gonzalez, F
    Kirwan, JP
    Minium, J
    Gaiser, H
    Rote, NS
    FERTILITY AND STERILITY, 2005, 84 : S9 - S10
  • [42] Polycystic ovary syndrome as a diabetes risk factor
    Moghetti, Paolo
    Tosi, Flavia
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 485 - 487
  • [43] Is polycystic ovary syndrome a risk factor for atherosclerosis?
    Bonn, D
    LANCET, 2000, 356 (9243): : 1742 - 1742
  • [44] Suppressed production of transforming growth factor-β2 mRNA in endometrium of women with polycystic ovary syndrome
    Zhdanov, AV
    Gadieva, FG
    Varlamov, DA
    Goryushkina, NA
    Faizullin, LZ
    Van'ko, LV
    Sukhikh, GT
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (03) : 276 - 278
  • [45] Suppressed Production of Transforming Growth Factor-β2 mRNA in Endometrium of Women with Polycystic Ovary Syndrome
    A. V. Zhdanov
    F. G. Gadieva
    D. A. Varlamov
    N. A. Goryushkina
    L. Z. Faizullin
    L. V. Van'ko
    G. T. Sukhikh
    Bulletin of Experimental Biology and Medicine, 2001, 131 : 276 - 278
  • [46] Evaluation of the Pro-inflammatory Cytokine Tumor Necrosis Factor-α in Adolescents with Polycystic Ovary Syndrome
    Pawelczak, Melissa
    Rosenthal, Jamie
    Milla, Sarah
    Liu, Ying-Hua
    Shah, Bina
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2014, 27 (06) : 356 - 359
  • [47] Effects of jnk inhibitor on inflammation and fibrosis in the ovary tissue of a rat model of polycystic ovary syndrome
    Bulut, Gulay
    Kurdoglu, Zehra
    Donmez, Yeliz Bozdemir
    Kurdoglu, Mertihan
    Erten, Remzi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 8774 - 8785
  • [48] ACTIVATION OF NUCLEAR FACTOR κB IN RESPONSE TO CREAM INGESTION IS RELATED TO OVARIAN ANDROGEN HYPERSECRETION IN POLYCYSTIC OVARY SYNDROME.
    Abdelhadi, O. A.
    Shepard, M. K.
    Sia, C. L.
    Garrett, T. J.
    Gonzalez, F.
    FERTILITY AND STERILITY, 2013, 100 (03) : S39 - S39
  • [49] Variations in the expression of the polycystic ovary syndrome phenotype
    Carmina, Enrico
    POLYCYSTIC OVARY SYNDROME: CURRENT CONTROVERSIES, FROM THE OVARY TO THE PANCREAS, 2008, : 123 - +